Hydrochloric Acid

Hydrochloric Acid

SCHEMBL813259

C1=CCC([Zr+2](=C(Cc2ccccc2)Cc2ccccc2)C2c3ccccc3-c3ccccc32)=C1.[Cl-].[Cl-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.31
CHRM1 known ✓ P11229 1/20 0.31
ACHE known ✓ P22303 1/20 0.31
SLC6A2 known ✓ P23975 1/20 0.31
SLC6A3 known ✓ Q01959 1/20 0.31
MAPT P10636 1/20 0.39
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A4 P31645 1/20 0.31
ADRA1A P35348 1/20 0.31
OPRM1 P35372 1/20 0.31
DRD3 P35462 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5079505 0.97 MAPT (0.39) MAPTCHRM2HTR1AADRA2ACHRM1
Hydrochloric Acid SCHEMBL5080404 0.92 MAPT (0.35) MAPT
Hydrochloric Acid SCHEMBL5077611 0.90 MAPT (0.34) MAPTACHE
Hydrochloric Acid SCHEMBL5084131 0.88 NPC1 (0.34) MAPT
Hydrochloric Acid SCHEMBL5080418 0.88 KEAP1 (0.33) MAPT
Hydrochloric Acid SCHEMBL5079586 0.86 MAPT (0.32) MAPT
Hydrochloric Acid SCHEMBL5083419 0.85 MAPT (0.30) MAPT
Hydrochloric Acid SCHEMBL1481260 0.85 HTR2C (0.34) MAPT
Hydrochloric Acid SCHEMBL5077685 0.84 ALDH1A1 (0.31)
Hydrochloric Acid SCHEMBL399507 0.84 MRGPRX4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2464670-B1 PROCESSES FOR CONTROLLING THE VISCOSITY OF POLYALPHAOLEFINS CHEMTURA CORP (US) 2014-11-19 EP claimed
EP-2464670-A1 PROCESSES FOR CONTROLLING THE VISCOSITY OF POLYALPHAOLEFINS Chemtura Corporation (US) 2012-06-20 EP claimed
US-8067652-B2 Processes for controlling the viscosity of polyalphaolefins CHEMTURA CORPORATION (US) 2011-11-29 US claimed
WO-2011019541-A1 PROCESSES FOR CONTROLLING THE VISCOSITY OF POLYALPHAOLEFINS CHEMTURA CORPORATION (US) 2011-02-17 WO claimed
US-20110040052-A1 Processes for Controlling the Viscosity of Polyalphaolefins LANXESS SOLUTIONS US INC. 2011-02-17 US claimed
EP-2464670-B1 PROCESSES FOR CONTROLLING THE VISCOSITY OF POLYALPHAOLEFINS CHEMTURA CORP (US) 2014-11-19 EP disclosed
EP-2395028-A1 Process for removal of residual catalyst components Chemtura Corporation (US) 2011-12-14 EP disclosed
US-8067652-B2 Processes for controlling the viscosity of polyalphaolefins CHEMTURA CORPORATION (US) 2011-11-29 US disclosed
EP-2059538-B1 PROCESS FOR REMOVAL OF RESIDUAL CATALYST COMPONENTS CHEMTURA CORP (US) 2011-10-19 EP disclosed
US-7943807-B2 Controlling branch level and viscosity of polyalphaolefins with propene addition CHEMTURA CORPORATION (US) 2011-05-17 US disclosed
US-20110092752-A1 Polyalphaolefins and processes for forming polyalphaolefins CHEMTURA CORPORATION, a corporation of the State of Delaware 2011-04-21 US disclosed
US-20110040052-A1 Processes for Controlling the Viscosity of Polyalphaolefins LANXESS SOLUTIONS US INC. 2011-02-17 US disclosed
WO-2003051943-A1 PROCESS FOR THE OLIGOMERIZATION OF αOLEFINS HAVING LOW UNSATURATION, THE RESULTING POLYMERS, AND LUBRICANTS CONTAINING SAME UNIROYAL CHEMICAL COMPANY, INC. (US) 2003-06-26 WO disclosed
EP-1309633-A2 PROCESS FOR PRODUCING LIQUID POLYALPHAOLEFIN POLYMER, METALLOCENE CATALYST THEREFOR AND LUBRICANTS CONTAINING THE SAME Uniroyal Chemical Company, Inc. (US) 2003-05-14 EP disclosed
EP-0892816-B1 POLYMERIZATION PROCESS FOR PRODUCING POLYOLEFIN ELASTOMER, CATION-GENERATING COCATALYST FOR ACTIVATING A METALLOCENE PROCATALYST, POLYOLEFIN ELASTOMER POSSESSING A UNIQUE COMBINATION OF PROPERTIES AND PRODUCTS MANUFACTURED THEREFROM UNIROYAL CHEM CO INC (US) 2002-12-04 EP disclosed
WO-2002014384-A2 PROCESS FOR PRODUCING LIQUID POLYALPHAOLEFIN POLYMER, METALLOCENE CATALYST THEREFOR AND LUBRICANTS CONTAINING THE SAME UNIROYAL CHEMICAL COMPANY, INC. (US) 2002-02-21 WO disclosed
US-6225426-B1 LIQUID PHASE POLYMERIZATION OF ETHYLENE, ALPHA-OLEFIN AND DIENE IN PRESENCE OF CATALYST COMPRISING MIXTURE OF METALLOCENE PROCATALYST AND ALUMINOXANE OR ALUMINOXANE AND TRIALKYLALUMINUM COMPOUND TOPRODUCE ELASTOMER UNIROYAL CHEMICAL COMPANY, INC. 2001-05-01 US disclosed
US-6147025-A SUBSTITUTING PART OR ALL OF THE ALUMINOXANE COCATALYST WITH A CATION-GENERATING COCATALYST UNIROYAL CHEMICAL COMPANY, INC, (US) 2000-11-14 US disclosed
US-6136744-A CATION-GENERATING COCATALYST COMPRISES A METAL COMPONENT, E.G., AN ALUMINUM COMPOUND, (2) A NEUTRAL METAL CONTAINING COMPONENT, E.G., A BORANE COMPOUND, AND (3) AN ANIONIC METAL COMPONENT, E.G., A METAL TETRAKIS(TETRAFLUOROPHENYL)BORATE. UNIROYAL CHEMICAL COMPANY, INC. (US) 2000-10-24 US disclosed
US-6060572-A LIQUID PHASE POLYMERIZATION OF ETHYLENE AND AT LEAST ONE OTHER ALPHA-OLEFIN USING A BULKY METALLOCENE CATALYST ACTIVATED BY AN ALUMOXANE OR A CATION-GENERATING METALLOCENE; HIGH MOLECULAR WEIGHT; HIGH VISCOSITY; LOW POLYDISPERSITY UNIROYAL CHEMICAL COMPANY, INC. (US) 2000-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092752-A1 Polyalphaolefins and processes for forming polyalphaolefins PAOX, ALOX12, ALOX15 CHRM2 2203/4885CHRM1 1477/4885ACHE 3159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.